The global oncology nutrition market is projected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. Factors such shift from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rise in number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the growth of the market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=166703967
The global market is developing rapidly and is witnessing intense competition with the presence of a wide number of players. In this competitive environment, companies are constantly bringing in new and improved products to the market. Current innovations in the market focus on enhancing the quality of human life through improvements in the process of gaining necessary nutrition. A research study on Nutri-jelly, a semisolid water-releasing food gel by Ampol Food Processing Co., LTD. (Thailand), showed improved health-related quality of life (HRQOL) in head and neck cancer patients and reduced the demand for nasogastric tube feeding. Currently, the Nutri-PEITC jelly is under the FDA clinical trial to investigate its safety and efficacy in head & neck cancer patients. Such advances in the market will lead to a change in the current market landscape.
On the basis of cancer type, the oncology nutrition market is segmented into head and neck cancer, stomach and gastrointestinal cancer, liver cancer, pancreatic cancer, esophageal cancer, lung cancer, breast cancer, blood cancer, and others. The other cancers segment mainly comprises of ovarian, prostate, and renal cancers. The head and neck cancers segment is expected to register the highest CAGR during the forecast period. The growth of this segment is primarily attributed to the high incidence of such cancer types due to increasing consumption of tobacco & alcohol and infection with human papillomavirus (HPV). Such cancers lead to conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting; that limit nutritional intake, increasing the need for the use of enteral feeding.
Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region is expected to register the highest CAGR during the forecast period. Growth in this market is largely driven by the increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, large population base, and rapid improvements in the health insurance sector.
